Protein and Peptide Therapeutics: Addressing bioanalytical demands of complicated peptides

This is the 3rd presentation in a brand new series of 4 webinars brought to you by Bioanalysis and Waters Corporation on ‘Opportunities in a Changing Landscape: Innovative LC/MS Solutions that will Usher in the Future of DMPK.’

In this webinar Erin Chambers, Principal Applications Chemist at Waters discussed ‘Protein and Peptide Therapeutics: Addressing bioanalytical demands of complicated peptides’

We hope you enjoy this presentation and if you have any questions for the speakers or host please do contact us by emailing [email protected].

The webinar series will tackle 4 important topics facing the DMPK laboratory today that you don’t want to miss! Other webinars in this series include:

• The Analysis of Teriparatide by LC-MS/MS – The Challenges and Lessons Learned presented by Elizabeth Thomas, Vice President and General Manager UK Bioanalytical Operations at ICON.

• The Shining Future of Accurate Mass Quantitation for Small and Large Molecules presented by Chris Evans, Pharmaceuticals Director at GlaxoSmithKline

• Innovation is not dead in DMPK – New platforms that deliver the future for Pharma presented by Mark Wrona, Principal Applications Chemist at Waters